Metallothionein expression in carcinoma of the gallbladder

Histopathology

Volumn 33, Issue 2, 1998, Pages 154-157

  Shukla, V K ^a   Aryya, N C ^a   Pitale, A ^a   Pandey, M ^a   Dixit, V K ^a   Reddy, C D ^a   Gautam, A ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Carcinogenesis; Cholecystitis; Gallbladder; Gallbladder carcinoma; Heavy metals; Metallothioneins

Indexed keywords

METALLOTHIONEIN;

ADULT; AGED; ARTICLE; CHRONIC CHOLECYSTITIS; CLINICAL ARTICLE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA; CHOLECYSTITIS; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOTHIONEIN; MIDDLE AGED;

EID: 0031840863     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00474.x     Document Type: Article

References (24)

1. Piehler JM, Crichlow RW. Primary carcinoma of the galbladder. Surg. Gynacol Obstet. 1978; 147; 929-942.
2. Shukla VK, Khandelwal C, Roy SK, Vaidya MP. Primary carcinoma of the gallbladder. A review of 16 years period at University Hospital. J. Surg. Oncol. 1985; 28; 32-35.
3. Shukla VK, Tiwari SC, Roy SK. Biliary bile acid in cholelithiasis and carcinoma of the gallbladder. Eur. J. Cancer Prev. 1993; 2; 155-160.
4. Pandey M, Vishwakarma RA, Khatri AK, Roy SK, Shukla VK. Bile, bacteria and gallbladder carcinogenesis. J. Surg. Oncol. 1995; 58; 282-283.
5. Pandey M, Khatri AK, Gautam A, Dubey SS; Shukla VK. Erythrocyte membrane fatty acid profile in patients with carcinoma of the gallbladder. J. Surg. Oncol. 1995; 58; 31-34.
6. Shukla VK, Shukla PK, Pandey M, Rao RB, Roy SK. Lipid peroxidation products in bile of patients with carcinoma of the gallbladder. A preliminary study. J. Surg. Oncol. 1994; 56; 258-262.
7. Pandy M, Shukla, PK, Gautam A, Rao BR, Roy SK, Shukla VK. Increased peroxidation of poly unsaturated fatty acids: A posssible link in the peroxidant pathogenesis of carcinoma of the gallbladder with cholelithiasis. Proc. XVI UICC International Cancer Congress 1994; 3; 2055-2058.
8. Kagi JH, Kojima Y. Chemistry and biochemistry of metallothionein. Experientia 1987; 52(Suppl.); 25-61.
9. Freedman JH, Peisach J. Resistance of cultured hepatoma cells to copper toxicity. Purification and characterization of the heptoma metallothionein. Biochem. Biophys. Acta 1989; 992; 145-154.
10. Frazier JM, Din WS. Role of metallothionein in induced resistance to cadmium toxicity in isolated rat hepatocytes. Experenntia Suppl. 1987; 52; 619-626.
11. Liu J, Kershhaw WC, Klassen CP. Rat primary hepatocyte cultures are a good model for examining metallothionein induced tolerance to cadmium toxicity in vitro. Cell. Dev. Biol. 1990; 26; 75-79.
12. Templeton DM, Cherian MG. Toxicological significance of metallothionein. Meth. Enzymol. 1991; 205; 11-24.
13. Kelly SL, Bose, A, Teicher BA, Hacker MP, Hamer DH, Lazo TS. Over expression of metallothionein confers resistance to anti-cancer drugs. Science 1988; 241; 1812-1815.
14. Elmes ME, Shukla VK, Zegler B et al. Metallotheonein immunoreactiviy as a prognostic marker in human melanoma. TEMA 1993; 8; 759-763.
15. Schmid KW, Ellis IO, Gee JM, et al. Presence and possible significance of immunocytochemically demonstratable metallothionein over expression in primary invasive ductal carcinoma of the breast. Virchows Arch A Pathol. Anat. Histopathol. 1993; 422; 153-159.
16. Cherian MG; Huang PC; Klaassen CD et al. Meeting Report. National Cancer Institute Workshop on the possible role of metallothionein in carcinogenesis. Cancer Res. 1993; 3; 922-925.
17. Jasani B; Elmes ME. Immunohistochemical detection of metallothionein. Method. Enzymol. 1991; 205; 95-107.
18. Douglas-Jones AG, Schmid KW, Bier B et al. Metallothionein expression in duel carcinoma in situ of the breast. Hum. Pathol. 1995; 26; 217-222.
19. Mulder TP, Verspaget HW, Janssem AR, deBruin PA, Griffioen G, Lamers CB. Neoplasia related changes of two copper (Cu) Zinc (Zn) proteins in the human colon. Free Radic. Biol. Med. 1990; 9; 501-506.
20. Helal T, Nasairi M, Khalifa A. Immunohistochemical markers of tumor prognosis in breast cancer in Egypt. Cancer Detect. Prev. 1997; 21; 201-206.
21. Monden N; Abe S; Sutoh I, Hishikawa Y, Kinugasa S, Nagasue N. Prognostic significance of the expression of metallothionein. glutathione-S-transferase-pi and P-glycoprotein in curatively resected gastric cancer. Oncology 1997; 54; 391-399.
22. Hishikawa Y, Abe S, Kinugasa S et al. Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 1997; 54; 342-347.
23. Krishnamurti CR, Vishwanathan P, Eds. Toxic Metals in Indian Environment. New Dehli: Tata McGraw Hill Publishing Company Ltd., 1990, 75-95.
24. Prakash A, Singh S, Gupta A, Gautam A, Shukla VK. Heavy metals and carcinoma gallbladder (Abst.) Ind. J. Gastroenterol. 1996 15 (Suppl 1): A6.